CELH
Celsius Holdings, Inc.
CELH has the edge over LMNR overall, supported by stronger fundamentals and stronger valuation.
LMNR
Limoneira Company
LMNR has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LMNR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Weak |
LMNR's revenue, profitability, cash flow and balance sheet are all currently under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
LMNR PE Valuation
LMNR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 23x next year's earnings.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
LMNR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect LMNR to return to profit, with revenue growing.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over LMNR on earnings quality, reporting a profit while its opponent remains loss making.
LMNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.44 | — |
| Q3 2026 | -$2.39 | -$1.86 |
| Q2 2026 | -$2.28 | -$2.16 |
| Q1 2026 | -$1.28 | -398% |
| Q4 2025 | -$0.93 | -333% |
| Q3 2025 | -$0.53 | -266% |
| Q2 2025 | -$0.12 | -$0.02 |
| Q1 2025 | $0.43 | +$0.98 |
| Q4 2024 | $0.40 | -20% |
LMNR lost $2.39 per share over the past year, and its loss has widened in each of the last six quarters.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over LMNR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over LMNR on profitability, with a higher operating margin.
LMNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $43.8M | -7.7% |
| Q2 2026 | $23.9M | -32% |
| Q1 2026 | $18.2M | -47% |
| Q4 2025 | $42.8M | -2.4% |
| Q3 2025 | $47.5M | -25% |
| Q2 2025 | $35.1M | -21% |
| Q1 2025 | $34.3M | -14% |
| Q4 2024 | $43.9M | +5.9% |
LMNR's revenue has slid since its 2024 peak: $44M last quarter, down 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.8% | -5.4 points |
| Q2 2026 | -91% | -81 points |
| Q1 2026 | -58% | -42 points |
| Q4 2025 | -26% | -20 points |
| Q3 2025 | -1.3% | -16 points |
| Q2 2025 | -9.5% | +1 points |
| Q1 2025 | -16% | +3.9 points |
| Q4 2024 | -6.3% | +17 points |
LMNR's operating margin was −6.8% last quarter, down 5.4 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over LMNR on cash generation, producing positive trailing cash flow while its opponent burns cash.
LMNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $316K | +$3.3M |
| Q2 2026 | -$4.5M | -150% |
| Q1 2026 | -$11.7M | +$1.2M |
| Q4 2025 | $942K | -86% |
| Q3 2025 | -$3M | -112% |
| Q2 2025 | $8.9M | +$12M |
| Q1 2025 | -$12.9M | -$2.6M |
| Q4 2024 | $6.6M | +$9.9M |
LMNR's free cash flow was −$15M over the past year, against −$364,000 the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over LMNR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
LMNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +37K shares |
| 1 year | +0.6% | +108K shares |
| 3 years | +1.9% | +341K shares |
| 5 years | -1.5% | -281K shares |
| Available history | +2.2% | +382K shares |
LMNR has 18M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q4 2020 | $2.9M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
LMNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 9.0x | High |
| Q1 2025 | 12.5x | High |
| Q4 2024 | 17.1x | High |
| Q4 2023 | 1.9x | Healthy |
| Q3 2023 | 1.1x | Healthy |
| Q2 2023 | 0.8x | Very low |
| Q1 2023 | 0.6x | Very low |
| Q4 2022 | 8.8x | High |
LMNR's net debt is about 9.0 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
LMNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.7 | Oversold |
| Stochastic | 7.0 | Oversold |
LMNR's weekly RSI is 30 (oversold) and its Stochastic is 7 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
LMNR PE vs Consumer Defensive Sector
| Metric | LMNR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
LMNR has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over LMNR on trend strength, trading above more of its moving averages.
LMNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.3 | 9.3% below |
| 20 week MA | $12.6 | 19% below |
| 50 week MA | $13.1 | 22% below |
| 100 week MA | $15.3 | 33% below |
| 200 week MA | $17.1 | 40% below |
LMNR is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
LMNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.2 | $17.0 | -12% |
| 2021 | $17.0 | $15.3 | -9.9% |
| 2022 | $15.3 | $12.2 | -20% |
| 2023 | $12.2 | $20.6 | +69% |
| 2024 | $20.6 | $24.4 | +18% |
| 2025 | $24.4 | $12.8 | -47% |
| 2026 YTD | $12.8 | $10.2 | -20% |
LMNR has the edge over CELH on returns for 2026, with the stronger performance.